<!-- google_ad_section_start -->Targeting Prostate Cancer<!-- google_ad_section_end -->
Health Forums

Go Back   Health Forums > Cancer > Cancers > alt.support.cancer

Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 02-28-2008, 07:12 PM
ironjustice
Guest
 
Posts: n/a
Default Targeting Prostate Cancer

Eating flaxseed may halt prostate cancer growth

04-Jun-2007 - Daily consumption of flaxseed may stop the growth of
prostate cancer tumours, according to research presented this weekend.

Flaxseed, which is rich in omega 3-fatty acids and fibre-related
compounds known as lignans, may interrupt the chain of events that
cause cells to divide irregularly and become cancerous, suggest
researchers from the Duke University Medical Center in the United
States.

"Our previous studies in animals and humans had shown a correlation
between flaxseed supplementation and slowed tumour growth, but the
participants in those studies had taken flaxseed in conjunction with a
low-fat diet," said Wendy Demark-Wahnefried, a researcher in Duke's
School of Nursing and lead investigator on the study.

"For this study, we demonstrated that it is flaxseed that primarily
offers the protective benefit," she confirmed.

The study involved men scheduled to undergo surgery for the treatment
of prostate cancer. The researchers gave them 30 grams of flaxseed
every day for an average of 30 days.

When the men's tumours were removed, the researchers were able to
determine how quickly the cancer cells had multiplied.

The men taking flaxseed, either alone or in conjunction with a low-fat
diet, were compared to men following just a low-fat diet, and men in a
control group, who did not alter or supplement their daily diet. Each
group was made up of about 40 participants.

Men in both of the flaxseed groups had the slowest rate of tumour
growth, according to the researchers.

The study was presented at the annual meeting of the American Society
of Clinical Oncology in Chicago on Saturday. NutraIngredients.com has
not seen the full results, and publication status is unknown.

"The results showed that the men who took just flaxseed as well as
those who took flaxseed combined with a low-fat diet did the best,
indicating that it is the flaxseed which is making the difference,"
Demark-Wahnefried said.

She suggested that as a source of omega-3 fatty acids, flaxseed may
alter how cancer cells lump together or cling to other body cells. It
could therefore help halt the cellular activity that leads to cancer
growth.

Moreover, lignans may have antiangiogenic properties, meaning they are
able to choke off a tumour's blood supply and stop it spreading, added
the researchers.

Participants took the flaxseed in a ground form to make it more
digestible and mixed it in drinks or sprinkled it on food such as
yogurt.

The researchers now hope to test the effectiveness of flaxseed
supplementation in patients with recurrent prostate cancer.

Over half a million news cases of prostate cancer are diagnosed every
year worldwide, and the cancer is the direct cause of over 200,000
deaths. Most worryingly, the incidence of the disease is increasing
with a rise of 1.7 per cent over 15 years.


-----------------------------------------

Dietary alpha-linolenic acid reduces COX-2 expression and induces
apoptosis of hepatoma cells
A. Vecchini*, V. Ceccarelli*, F. Susta*, P. Caligiana*, P.
Orvietani*,
L. Binaglia1,*, G. Nocentini, C. Riccardi, G. Calviello, P. Palozza,
N. Maggiano and P. Di Nardo**

* Department of Internal Medicine, Section of Biochemistry,
University
of Perugia, Perugia, Italy
Department of Clinical and Experimental Medicine, Section of
Pharmacology, University of Perugia, Perugia, Italy
Institute of General Pathology, Catholic University, Rome, Italy
** Department of Internal Medicine, Laboratory of Cellular and
Molecular Cardiology, University of Roma "Tor Vergata," Rome, Italy


1 To whom correspondence should be addressed. e-mail:
binag...@unipg.it


Fatty acid synthetase (FAS) is overexpressed in various tumor
tissues,
and its inhibition and/or malonyl-CoA accumulation have been
correlated to apoptosis of tumor cells. It is widely recognized that
both -3 and -6 polyunsaturated fatty acids (PUFAs) depress FAS
expression in liver, although epidemiological and experimental
reports
attribute antitumor properties only to -3 PUFA. Therefore, we
investigated whether lipogenic gene expression in tumor cells is
differently regulated by -6 and -3 PUFAs. Morris hepatoma 3924A cells
were implanted subcutaneously in the hind legs of ACI/T rats
preconditioned with high-lipid diets enriched with linoleic acid or -
linolenic acid. Both-high lipid diets depressed the expression of FAS
and acetyl-CoA carboxylase in tumor tissue, this effect correlating
with a decrease in the mRNA level of their common sterol regulatory
element binding protein-1 transcription factor. Hepatoma cells grown
in rats on either diet did not accumulate malonyl-CoA. Apoptosis of
hepatoma cells was induced by the alpha-linolenic acid-enriched diet
but not by the linoleic acid-enriched diet.


Therefore, in this experimental model, apoptosis is apparently
independent of the inhibition of fatty acid synthesis and of malonyl-
CoA cytotoxicity. Conversely, it was observed that apoptosis induced
by the alpha-linolenic acid-enriched diet correlated with a decrease
in arachidonate content in hepatoma cells and decreased
cyclooxygenase-2 expression.


Abbreviations: ACC, acetyl-CoA carboxylase; C/EBP, CCAAT enhancer
binding protein; COX-2, cyclooxygenase-2; CPT-1, carnitine
palmitoyltransferase-1; FAS, fatty acid synthetase; PPAR, peroxisome
proliferator-activated receptor-; SCAP, sterol regulatory element
binding protein-1 cleavage activating protein; S1P, site-1 protease;
S2P, site-2 protease; SREBP-1, sterol regulatory element binding
protein-1


Supplementary key words cyclooxygenase-2 * polyunsaturated fatty
acids
* sterol regulatory element binding protein 1
Originally published In Press as doi:10.1194/jlr.M300396-JLR200 on
October 16, 2003
Journal of Lipid Research, Vol. 45, 308-316, February 2004
Copyright (c) 2004 by American Society for Biochemistry and Molecular
Biology


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com


Man Is A Herbivore!
http://tinyurl.com/a3cc3


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk


Reply With Quote
  #2  
Old 03-03-2008, 01:31 PM
Homenet
Guest
 
Posts: n/a
Default Re: Targeting Prostate Cancer

On 28 Feb, 17:59, ironjustice <teamtan...@hotmail.com> wrote:
> Eating flaxseed may halt prostate cancer growth
>
> 04-Jun-2007 - Daily consumption of flaxseed may stop the growth of
> prostate cancer tumours, according to research presented this weekend.
>
> Flaxseed, which is rich in omega 3-fatty acids and fibre-related
> compounds known as lignans, may interrupt the chain of events that
> cause cells to divide irregularly and become cancerous, suggest
> researchers from the Duke University Medical Center in the United
> States.
>
> "Our previous studies in animals and humans had shown a correlation
> between flaxseed supplementation and slowed tumour growth, but the
> participants in those studies had taken flaxseed in conjunction with a
> low-fat diet," said Wendy Demark-Wahnefried, a researcher in Duke's
> School of Nursing and lead investigator on the study.
>
> "For this study, we demonstrated that it is flaxseed that primarily
> offers the protective benefit," she confirmed.
>
> The study involved men scheduled to undergo surgery for the treatment
> of prostate cancer. The researchers gave them 30 grams of flaxseed
> every day for an average of 30 days.
>
> When the men's tumours were removed, the researchers were able to
> determine how quickly the cancer cells had multiplied.
>
> The men taking flaxseed, either alone or in conjunction with a low-fat
> diet, were compared to men following just a low-fat diet, and men in a
> control group, who did not alter or supplement their daily diet. Each
> group was made up of about 40 participants.
>
> Men in both of the flaxseed groups had the slowest rate of tumour
> growth, according to the researchers.
>
> The study was presented at the annual meeting of the American Society
> of Clinical Oncology in Chicago on Saturday. NutraIngredients.com has
> not seen the full results, and publication status is unknown.
>
> "The results showed that the men who took just flaxseed as well as
> those who took flaxseed combined with a low-fat diet did the best,
> indicating that it is the flaxseed which is making the difference,"
> Demark-Wahnefried said.
>
> She suggested that as a source of omega-3 fatty acids, flaxseed may
> alter how cancer cells lump together or cling to other body cells. It
> could therefore help halt the cellular activity that leads to cancer
> growth.
>
> Moreover, lignans may have antiangiogenic properties, meaning they are
> able to choke off a tumour's blood supply and stop it spreading, added
> the researchers.
>
> Participants took the flaxseed in a ground form to make it more
> digestible and mixed it in drinks or sprinkled it on food such as
> yogurt.
>
> The researchers now hope to test the effectiveness of flaxseed
> supplementation in patients with recurrent prostate cancer.
>
> Over half a million news cases of prostate cancer are diagnosed every
> year worldwide, and the cancer is the direct cause of over 200,000
> deaths. Most worryingly, the incidence of the disease is increasing
> with a rise of 1.7 per cent over 15 years.
>
> -----------------------------------------
>
> Dietary alpha-linolenic acid reduces COX-2 expression and induces
> apoptosis of hepatoma cells
> A. Vecchini*, V. Ceccarelli*, F. Susta*, P. Caligiana*, P.
> Orvietani*,
> L. Binaglia1,*, G. Nocentini, C. Riccardi, G. Calviello, P. Palozza,
> N. Maggiano and P. Di Nardo**
>
> * Department of Internal Medicine, Section of Biochemistry,
> University
> of Perugia, Perugia, Italy
> Department of Clinical and Experimental Medicine, Section of
> Pharmacology, University of Perugia, Perugia, Italy
> Institute of General Pathology, Catholic University, Rome, Italy
> ** Department of Internal Medicine, Laboratory of Cellular and
> Molecular Cardiology, University of Roma "Tor Vergata," Rome, Italy
>
> 1 To whom correspondence should be addressed. e-mail:
> binag...@unipg.it
>
> Fatty acid synthetase (FAS) is overexpressed in various tumor
> tissues,
> and its inhibition and/or malonyl-CoA accumulation have been
> correlated to apoptosis of tumor cells. It is widely recognized that
> both -3 and -6 polyunsaturated fatty acids (PUFAs) depress FAS
> expression in liver, although epidemiological and experimental
> reports
> attribute antitumor properties only to -3 PUFA. Therefore, we
> investigated whether lipogenic gene expression in tumor cells is
> differently regulated by -6 and -3 PUFAs. Morris hepatoma 3924A cells
> were implanted subcutaneously in the hind legs of ACI/T rats
> preconditioned with high-lipid diets enriched with linoleic acid or -
> linolenic acid. Both-high lipid diets depressed the expression of FAS
> and acetyl-CoA carboxylase in tumor tissue, this effect correlating
> with a decrease in the mRNA level of their common sterol regulatory
> element binding protein-1 transcription factor. Hepatoma cells grown
> in rats on either diet did not accumulate malonyl-CoA. Apoptosis of
> hepatoma cells was induced by the alpha-linolenic acid-enriched diet
> but not by the linoleic acid-enriched diet.
>
> Therefore, in this experimental model, apoptosis is apparently
> independent of the inhibition of fatty acid synthesis and of malonyl-
> CoA cytotoxicity. Conversely, it was observed that apoptosis induced
> by the alpha-linolenic acid-enriched diet correlated with a decrease
> in arachidonate content in hepatoma cells and decreased
> cyclooxygenase-2 expression.
>
> Abbreviations: ACC, acetyl-CoA carboxylase; C/EBP, CCAAT enhancer
> binding protein; COX-2, cyclooxygenase-2; CPT-1, carnitine
> palmitoyltransferase-1; FAS, fatty acid synthetase; PPAR, peroxisome
> proliferator-activated receptor-; SCAP, sterol regulatory element
> binding protein-1 cleavage activating protein; S1P, site-1 protease;
> S2P, site-2 protease; SREBP-1, sterol regulatory element binding
> protein-1
>
> Supplementary key words cyclooxygenase-2 * polyunsaturated fatty
> acids
> * sterol regulatory element binding protein 1
> Originally published In Press as doi:10.1194/jlr.M300396-JLR200 on
> October 16, 2003
> Journal of Lipid Research, Vol. 45, 308-316, February 2004
> Copyright (c) 2004 by American Society for Biochemistry and Molecular
> Biology
>
> Who loves ya.
> Tom
>
> Jesus Was A Vegetarian!http://jesuswasavegetarian.7h.com
>
> Man Is A Herbivore!http://tinyurl.com/a3cc3
>
> DEAD PEOPLE WALKINGhttp://tinyurl.com/zk9fk


Nice post. Flaxseed oil is definatly a big helper here.

------------------------------------
http://mesothelioma.mypressonline.com/index.html - Information and
advice on Mesothelioma cancer
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is Off
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Prostate Cancer: Screening for Prostate Cancer J alt.support.cancer.prostate 0 01-28-2008 09:40 PM
Think You Have A Prostate Problem Or Prostate Cancer? guage alt.support.cancer.prostate 1 12-02-2007 11:01 PM
Advanced Prostate Cancer and Immune Therapies for Prostate Cancer california_chief alt.support.cancer.prostate 0 06-11-2007 08:56 PM
Targeting iron in cancer ironjustice@aol.com alt.support.cancer 0 02-21-2007 02:01 AM
There Are Currently No Less Than 220 Emerging Therapeutics Targeting Prostate Cancer, from Early Preclinical to Marketed Drugs Dave P alt.support.cancer.prostate 7 01-16-2007 10:41 PM


All times are GMT. The time now is 07:59 AM.


Powered by vBulletin® Version 3.7.2
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
Search Engine Optimization by vBSEO 3.2.0
     
   
 

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41